Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 01 Dec 2017
At a glance
- Drugs Dutasteride (Primary)
- Indications Prostate cancer
- Focus Biomarker; Pharmacodynamics; Pharmacogenomic
- 27 Nov 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 27 Nov 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
- 10 Jun 2017 Biomarkers information updated